AUTOLYMPHOCYTE THERAPY - II - DEPENDENCE OF IN-VIVO ANTITUMOR SPECIFICITY AND LONG-TERM IMMUNITY AGAINST MURINE MELANOMA AND CARCINOMA ON EX-VIVO ACTIVATED DONOR MEMORY T-CELLS (VOL 71, PG 325, 1994)
Je. Gold et Me. Osband, AUTOLYMPHOCYTE THERAPY - II - DEPENDENCE OF IN-VIVO ANTITUMOR SPECIFICITY AND LONG-TERM IMMUNITY AGAINST MURINE MELANOMA AND CARCINOMA ON EX-VIVO ACTIVATED DONOR MEMORY T-CELLS (VOL 71, PG 325, 1994), Clinical immunology and immunopathology (Print), 87(3), 1998, pp. 314-314